HCA
HCA HealthcarePrevious close
430.43
Change
+6.61 / +1.56%
52-Week Range
353.99 – 556.52
P/E (TTM)
13.4
Forward P/E
12.7
Based on consensus earnings for the next 12 months
Market Cap
$93.2B
1M
+6.28%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.4M / 1.4M
0.95× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-14 | $20.2B | 7.59 / 7.54 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-24 | $19.1B | 7.15 / 7.21 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-01-27 | $75.6B | 8.01 / 7.53 | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-10-24 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-25 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-01 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 14 of its 5-year rangeCheap
5-year range 12.4 – 19.1 · Median 15.9
Last 4 quarters: $9.1B in buybacks + $682M in dividends, 10.53% of market cap combined
P/E (TTM)
13.4
P/B
—
P/S
1.2
Dividend Yield
0.95%
Earnings Reaction
Over the last 6 reports, the stock moved ±3.0% on average on the first trading day after, rising 5 times
Most recent +4.19%
Volatility & Correlation
1-year beta 0.18 · Correlation with S&P 500 0.07Low beta
Annualized volatility 31% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 19.11 | +4.3% | — | 1.62 | 7.15 |
| FY2025 Q4 | 19.51 | +6.7% | — | 1.88 | 8.09 |
| FY2025 Q3 | 19.16 | +9.6% | — | 1.64 | 6.96 |
| FY2025 Q2 | 18.61 | +6.4% | — | 1.65 | 6.83 |
| FY2025 Q1 | 18.32 | +5.7% | — | 1.61 | 6.45 |
| FY2024 Q4 | 18.29 | +5.7% | — | 1.44 | 5.66 |
| FY2024 Q3 | 17.49 | +7.9% | — | 1.27 | 4.88 |
| FY2024 Q2 | 17.49 | +10.3% | — | 1.46 | 5.53 |
| FY2024 Q1 | 17.34 | +11.2% | — | 1.59 | 5.93 |
| FY2023 Q4 | 17.30 | +11.7% | — | 1.61 | 5.92 |
| FY2023 Q3 | 16.21 | +8.3% | — | 1.08 | 3.91 |
| FY2023 Q2 | 15.86 | +7.0% | — | 1.19 | 4.29 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| HCA | 13.4 | +4.3% | — | +6.28% | Bullish |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |